ATE535538T1 - Verfahren zur herstellung von guggulsteronen und guggulsterol - Google Patents
Verfahren zur herstellung von guggulsteronen und guggulsterolInfo
- Publication number
- ATE535538T1 ATE535538T1 AT04729374T AT04729374T ATE535538T1 AT E535538 T1 ATE535538 T1 AT E535538T1 AT 04729374 T AT04729374 T AT 04729374T AT 04729374 T AT04729374 T AT 04729374T AT E535538 T1 ATE535538 T1 AT E535538T1
- Authority
- AT
- Austria
- Prior art keywords
- formula
- guggulsterol
- guggulsterones
- producing
- guggulsterone
- Prior art date
Links
- WDXRGPWQVHZTQJ-AUKWTSKRSA-N Guggulsterone Natural products C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(=O)/C(=C/C)[C@@]1(C)CC2 WDXRGPWQVHZTQJ-AUKWTSKRSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- WDXRGPWQVHZTQJ-UHFFFAOYSA-N trans-guggulsterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CC(=O)C(=CC)C1(C)CC2 WDXRGPWQVHZTQJ-UHFFFAOYSA-N 0.000 abstract 3
- WDXRGPWQVHZTQJ-OSJVMJFVSA-N (8r,9s,10r,13s,14s,17z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(=O)\C(=C/C)[C@@]1(C)CC2 WDXRGPWQVHZTQJ-OSJVMJFVSA-N 0.000 abstract 2
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract 2
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract 2
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract 2
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- WDXRGPWQVHZTQJ-NRJJLHBYSA-N Guggulsterone E Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(=O)C(=CC)[C@@]1(C)CC2 WDXRGPWQVHZTQJ-NRJJLHBYSA-N 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003028 elevating effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C07J33/007—Cyclic thioketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020030025936A KR100543542B1 (ko) | 2003-04-24 | 2003-04-24 | 4-안드로스텐-3,17-디온으로부터 구굴스테론의 제조방법및 이를 제조하기 위한 중간체 |
| KR1020030025904A KR100639655B1 (ko) | 2003-04-24 | 2003-04-24 | 16α,17α-에폭시프레그네놀론으로부터4,17(20)-프로스타디엔-3,16-디온의 제조방법 및 이를제조하기 위한 중간체 |
| KR1020030025962A KR100543544B1 (ko) | 2003-04-24 | 2003-04-24 | 테스토스테론으로부터 구굴스테론의 제조방법 및 이를제조하기 위한 중간체 |
| KR1020030025989A KR100543547B1 (ko) | 2003-04-24 | 2003-04-24 | 프로제스테론으로부터 구굴스테론의 제조방법 및 이를제조하기 위한 중간체 |
| KR1020030025919A KR100543533B1 (ko) | 2003-04-24 | 2003-04-24 | 5-안드로스텐-3β-올-17-온으로부터4,17(20)-프로스타디엔-3,16-디온의 제조방법 및 이를제조하기 위한 중간체 |
| PCT/KR2004/000950 WO2004094450A1 (en) | 2003-04-24 | 2004-04-24 | Process for preparing guggulsterones and guggulsterol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE535538T1 true ATE535538T1 (de) | 2011-12-15 |
Family
ID=36479563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04729374T ATE535538T1 (de) | 2003-04-24 | 2004-04-24 | Verfahren zur herstellung von guggulsteronen und guggulsterol |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070055072A1 (de) |
| EP (4) | EP2251346A3 (de) |
| JP (2) | JP4895804B2 (de) |
| AT (1) | ATE535538T1 (de) |
| AU (1) | AU2004232615B2 (de) |
| BR (1) | BRPI0409767A (de) |
| CA (1) | CA2523369C (de) |
| ES (1) | ES2376549T3 (de) |
| WO (1) | WO2004094450A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004232615B2 (en) * | 2003-04-24 | 2007-05-24 | Seoul National University Industry Foundation | Process for preparing guggulsterones and guggulsterol |
| EP1886685A1 (de) | 2006-08-11 | 2008-02-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methoden, Verwendungen und Zusammensetzungen zur Modulation der Replikation von HCV durch Aktivierung oder Hemmung des Farnesoid X Rezeptors |
| US9637515B2 (en) | 2006-11-06 | 2017-05-02 | Jina Pharmaceuticals, Inc. | Guggulphospholipid methods and compositions |
| CN101195648A (zh) * | 2007-12-03 | 2008-06-11 | 邵阳市科瑞化学品有限公司 | 制备二烯甾酮的方法 |
| CN113082960B (zh) * | 2021-04-09 | 2022-05-20 | 辽宁科技大学 | 一种宽温度窗口烟气脱硫用低共熔溶剂及生产、再生方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3141028A (en) * | 1962-10-02 | 1964-07-14 | Searle & Co | 16-oxygenated pregna-4, 17(20)-[trans] dien-3-ones and intermediates thereto |
| EP0447706A1 (de) | 1990-03-22 | 1991-09-25 | Cipla Limited | Verfahren zur Herstellung einer pharmazeutischen aktiven Mischung der Guggulsteronen Z und E |
| DE4313089A1 (de) * | 1993-04-22 | 1994-10-27 | Basf Ag | Verfahren zur Herstellung von 13-(Z)-Retinsäure |
| KR100446068B1 (ko) * | 2001-10-23 | 2004-08-30 | 동방에프티엘 주식회사 | 구굴스테론의 제조방법 |
| WO2004021975A2 (en) * | 2002-09-03 | 2004-03-18 | Ganga Raju Gokaraju | An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones |
| AU2004232615B2 (en) * | 2003-04-24 | 2007-05-24 | Seoul National University Industry Foundation | Process for preparing guggulsterones and guggulsterol |
-
2004
- 2004-04-24 AU AU2004232615A patent/AU2004232615B2/en not_active Ceased
- 2004-04-24 JP JP2006507820A patent/JP4895804B2/ja not_active Expired - Fee Related
- 2004-04-24 WO PCT/KR2004/000950 patent/WO2004094450A1/en not_active Ceased
- 2004-04-24 BR BRPI0409767-0A patent/BRPI0409767A/pt not_active IP Right Cessation
- 2004-04-24 AT AT04729374T patent/ATE535538T1/de active
- 2004-04-24 US US10/554,439 patent/US20070055072A1/en not_active Abandoned
- 2004-04-24 EP EP10168887A patent/EP2251346A3/de not_active Withdrawn
- 2004-04-24 EP EP13153819.1A patent/EP2594577A1/de not_active Withdrawn
- 2004-04-24 CA CA002523369A patent/CA2523369C/en not_active Expired - Fee Related
- 2004-04-24 ES ES04729374T patent/ES2376549T3/es not_active Expired - Lifetime
- 2004-04-24 EP EP04729374A patent/EP1620455B1/de not_active Expired - Lifetime
- 2004-04-24 EP EP10168885A patent/EP2284176A1/de not_active Withdrawn
-
2011
- 2011-04-05 JP JP2011083955A patent/JP5430603B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20070055072A1 (en) | 2007-03-08 |
| BRPI0409767A (pt) | 2006-05-30 |
| EP2594577A1 (de) | 2013-05-22 |
| EP1620455A1 (de) | 2006-02-01 |
| EP1620455A4 (de) | 2009-08-05 |
| CA2523369A1 (en) | 2004-11-04 |
| EP1620455B1 (de) | 2011-11-30 |
| AU2004232615A1 (en) | 2004-11-04 |
| JP5430603B2 (ja) | 2014-03-05 |
| ES2376549T3 (es) | 2012-03-14 |
| EP2284176A1 (de) | 2011-02-16 |
| EP2251346A3 (de) | 2011-02-16 |
| CA2523369C (en) | 2009-08-04 |
| JP2006524237A (ja) | 2006-10-26 |
| AU2004232615B2 (en) | 2007-05-24 |
| WO2004094450A1 (en) | 2004-11-04 |
| EP2251346A2 (de) | 2010-11-17 |
| JP4895804B2 (ja) | 2012-03-14 |
| JP2011157382A (ja) | 2011-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE506356T1 (de) | Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen | |
| ATE495177T1 (de) | Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen | |
| DE502004009142D1 (de) | Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen | |
| EP1072592A3 (de) | 4-Arylpiperidinderivate zur Behandlung von Pruritus | |
| WO2003039480A3 (en) | Method of treating disorder related to high cholesterol concentration | |
| DE60335616D1 (de) | Verfahren zur herstellung von siliciumeinkristallen, und dadurch hergestellte siliciumeinkristallwafer und siliciumeinkristallstab | |
| DE69838146D1 (de) | Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben | |
| ATE442363T1 (de) | Verfahren zur herstellung von pyridinverbindungen | |
| ATE380816T1 (de) | Substituierte imidazopyrimidine zur prävention und behandlung von krebs | |
| ATE354583T1 (de) | Verfahren zur herstellung c-7 substituierter 5- androstene | |
| TW200610793A (en) | Composition for forming insulating film, method for producing the same, silica-based insulating film and method for forming the same | |
| ATE355296T1 (de) | Verfahren zur herstellung von (e,z) 3-(2- aminoethoxyimino)-androstane-6,17-dione und analoge | |
| EP1620455A4 (de) | Verfahren zur herstellung von guggulsteronen und guggulsterol | |
| ATE424833T1 (de) | Orale immunstimulierung von säugern, vögeln und reptilien durch (1-4)-verknüpfte beta-d- mannuronsäure | |
| ATE265413T1 (de) | Verfahren und vorrichtung zur herstellung von monofonktionellen haloameisensäurearylestern | |
| ATE501120T1 (de) | Verfahren zur herstellung von isoindolderivaten | |
| MXPA05011677A (es) | Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina. | |
| WO2003053352A3 (en) | Therapeutic compounds for treating dyslipidemic conditions | |
| ATE533820T1 (de) | Verfahren zur herstellung von polysilylestern und deren verwendungen | |
| DE60107292D1 (de) | Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
| DE50115225D1 (de) | Verfahren zur Herstellung von Beta-Hydroxyalkylamiden | |
| ATE363460T1 (de) | Verfahren zur herstellung von fluorhalogenalkanen | |
| ATE364590T1 (de) | Verfahren zur herstellung von1-acetoxy-3- (substituiertes phenyl)propenen | |
| TW200600013A (en) | 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | |
| DE60118247D1 (de) | Magnetfeldofen und betriebsverfahren zur herstellung von bandförmigen dendritischen kristallen |